Brussels-Capital Region

Showing 1-8 of 8 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
LACMETA – Manipulating lactate metabolism to regulate T cell responses in type 1 diabetes	Université Libre de Bruxelles	Alessandra Cardozo	Cures	01-October-2025 to 30-September-2028	$200,000.00
Towards a first-in-man trial for beta cell imaging using a single domain antibody targeting DPP6	Université Libre de Bruxelles	Decio Eizirik	Cures	01-February-2026 to 31-January-2029	$1,137,649.00
The central role for NLRC5 in the dialog between β-cells and the immune system in type 1 diabetes	Université Libre de Bruxelles	Decio Eizirik	Cures	01-June-2022 to 30-November-2025	$598,503.00
Mining the transcriptomic signatures of pancreatic beta-cells and the target tissues of other autoimmune and inflammatory endocrine or brain diseases to identify common mechanisms and novel therapies	Université Libre de Bruxelles	Decio Eizirik	Cures	01-May-2023 to 30-April-2026	$698,821.00
SMART-ISLETs: Stem Cell-Derived Smart Islets for Improved Transplantation Outcome.	Université Libre de Bruxelles	Esteban Gurzov	Cures	01-July-2024 to 30-June-2026	$269,778.00
Unveiling new targets to protect β-cells in type 1 diabetes via in-depth comparison between α- and β-cell features	Université Libre de Bruxelles	Maria Eugenia Martin-Vazquez Garcia	Cures	01-May-2025 to 30-April-2028	$241,710.00
Continuous monitoring of glycemic variability to predict dys- and hyperglycemia in asymptomatic type 1 diabetes	Vrije Universiteit Brussel	Bart Keymeulen	Cures	01-June-2022 to 31-May-2026	$1,199,551.50
VASC-ENHANCE: Exploiting Vascular Signals for Enhanced Maturation of iPSC-derived Beta-Like Cells	Vrije Universiteit Brussel	Willem Staels	Cures	01-March-2024 to 28-February-2029	$997,050.00